Hollings Renton, Director at CEPHEID (CPHD), sold 7,500 shares at $24.82 ($186K) on 2011-02-17, disclosed to the SEC on 2011-02-22.
Open-market sale of $186k CPHD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |